Avidity Biosciences (RNA) Stock Forecast, Price & News

Avidity Biosciences (NASDAQ:RNA) Frequently Asked Questions

Is Avidity Biosciences a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avidity Biosciences in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Avidity Biosciences stock.
View analyst ratings for Avidity Biosciences or view top-rated stocks.

When is Avidity Biosciences' next earnings date?

Avidity Biosciences is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Avidity Biosciences.

How were Avidity Biosciences' earnings last quarter?

Avidity Biosciences, Inc. (NASDAQ:RNA) posted its quarterly earnings results on Tuesday, May, 10th. The biotechnology company reported ($0.71) earnings per share for the quarter, beating the consensus estimate of ($0.80) by $0.09. Avidity Biosciences had a negative net margin of 1,525.48% and a negative trailing twelve-month return on equity of 36.26%.
View Avidity Biosciences' earnings history.

What price target have analysts set for RNA?

5 brokers have issued 12-month target prices for Avidity Biosciences' stock. Their forecasts range from $36.00 to $59.00. On average, they anticipate Avidity Biosciences' stock price to reach $49.60 in the next twelve months. This suggests a possible upside of 239.0% from the stock's current price.
View analysts' price targets for Avidity Biosciences or view top-rated stocks among Wall Street analysts.

Who are Avidity Biosciences' key executives?

Avidity Biosciences' management team includes the following people:

• Dr. Troy Edward Wilson J.D., Ph.D., Co-Founder & Chairman (Age 53, Pay $65k)
• Ms. Sarah Boyce, Pres, CEO & Director (Age 50, Pay $1M)
• Mr. Michael F. MacLean, CFO & Chief Bus. Officer (Age 56, Pay $650.38k)
• Dr. W. Michael Flanagan Ph.D., Chief Technical Officer (Age 60, Pay $1M)
• Dr. Arthur A. Levin Ph.D., Chief Scientific Officer (Age 68, Pay $662.86k)
• Mr. Joseph T. Baroldi, Consultant (Age 43, Pay $642.43k)
• Prof. Mark E. Davis, Scientific Founder, Member of Scientific Advisory Board and Member of Board of Mang.s
• Dr. Frank McCormick Ph.D., Scientific Founder & Member of Scientific Advisory Board (Age 72)
• Ms. Kathleen Gallagher, Sr. VP of Corp. Communications & Investor Relations
• Dr. John W. Wallen III, VP of Intellectual Property, Gen. Counsel & Sec. (Age 64)

Who are some of Avidity Biosciences' key competitors?

Some companies that are related to Avidity Biosciences include Indivior (INVVY), Prestige Consumer Healthcare (PBH), ACADIA Pharmaceuticals (ACAD), Harmony Biosciences (HRMY), EQRx (EQRX), Insmed (INSM), Arvinas (ARVN), Corcept Therapeutics (CORT), Amicus Therapeutics (FOLD), Mirati Therapeutics (MRTX), OPKO Health (OPK), PTC Therapeutics (PTCT), Sage Therapeutics (SAGE), Amphastar Pharmaceuticals (AMPH) and Schrödinger (SDGR).
View all of RNA's competitors.

What other stocks do shareholders of Avidity Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avidity Biosciences investors own include GTX (GTXI), Inovio Pharmaceuticals (INO), Novavax (NVAX), Sarepta Therapeutics (SRPT), Avid Bioservices (CDMO), Dynavax Technologies (DVAX), iBio (IBIO), Intel (INTC), Ariad Pharmaceuticals (ARIA) and Corcept Therapeutics (CORT).

When did Avidity Biosciences IPO?

(RNA) raised $150 million in an initial public offering (IPO) on Friday, June 12th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. Cowen, SVB Leerink, Credit Suisse and Wells Fargo Securities acted as the underwriters for the IPO.

What is Avidity Biosciences' stock symbol?

Avidity Biosciences trades on the NASDAQ under the ticker symbol "RNA."

Who are Avidity Biosciences' major shareholders?

Avidity Biosciences' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Aaron Wealth Advisors LLC (8.01%), BlackRock Inc. (6.56%), Vanguard Group Inc. (4.62%), RA Capital Management L.P. (4.36%), State Street Corp (3.30%) and Wellington Management Group LLP (2.28%). Company insiders that own Avidity Biosciences stock include Arthur A Levin and Rtw Investments, Lp.
View institutional ownership trends for Avidity Biosciences.

Which major investors are selling Avidity Biosciences stock?

RNA stock was sold by a variety of institutional investors in the last quarter, including US Bancorp DE, Citigroup Inc., BlackRock Inc., Harbor Capital Advisors Inc., JPMorgan Chase & Co., Metropolitan Life Insurance Co NY, Northern Trust Corp, and TD Asset Management Inc..
View insider buying and selling activity for Avidity Biosciences or view top insider-selling stocks.

Which major investors are buying Avidity Biosciences stock?

RNA stock was bought by a variety of institutional investors in the last quarter, including Aaron Wealth Advisors LLC, RA Capital Management L.P., Vanguard Group Inc., State Street Corp, Dimensional Fund Advisors LP, Walleye Capital LLC, Wellington Management Group LLP, and The Manufacturers Life Insurance Company .
View insider buying and selling activity for Avidity Biosciences or or view top insider-buying stocks.

How do I buy shares of Avidity Biosciences?

Shares of RNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avidity Biosciences' stock price today?

One share of RNA stock can currently be purchased for approximately $14.63.

How much money does Avidity Biosciences make?

Avidity Biosciences has a market capitalization of $728.03 million and generates $9.33 million in revenue each year. The biotechnology company earns $-118.01 million in net income (profit) each year or ($2.910010) on an earnings per share basis.

How many employees does Avidity Biosciences have?

Avidity Biosciences employs 125 workers across the globe.

What is Avidity Biosciences' official website?

The official website for Avidity Biosciences is www.aviditybiosciences.com.

How can I contact Avidity Biosciences?

Avidity Biosciences' mailing address is 10975 N. TORREY PINES RD. SUITE 150, LA JOLLA CA, 92037. The biotechnology company can be reached via phone at 858-401-7900 or via email at [email protected].